iShares U.S. Pharmaceuticals ETF Price & Performance (IHE)

U.S. markets experienced a sharp downturn, with the Nasdaq dropping nearly 10% from its December highs. Concerns over new tariffs and economic outlooks have rattled investor confidence, causing major tech stocks like Tesla and Nvidia to tumble. The S&P 500 and Dow Jones also posted declines, reflecting broader market unease.1

Ahead of the Federal Reserve's policy announcement, U.S. equity futures showed mixed performance. The Nasdaq gained 0.3% while the Dow Jones edged down 0.1%. Investors are closely monitoring potential rate decisions and their implications for borrowing costs and economic growth.2

Pfizer has sold its remaining stake in Haleon for £2.5 billion, marking its full exit from the UK consumer healthcare firm. This move strengthens Haleon’s position, with plans for substantial share buybacks. BlackRock now holds the largest stake in the company, signaling a shift in shareholder dynamics.3